Durability of sustained virologic response in patients with chronic hepatitis C after treatment with interferon α-2b alone or in combination with ribavirin.

被引：0
|
作者：
McHutchison, JG
Davis, GL
Esteban-Mur, R
Poynard, T
Ling, MH
Garaud, JJ
Albrecht, J
机构：
[1] Scripps Clin, La Jolla, CA USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Hosp Gen Valle Hebron, Barcelona, Spain
[4] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[5] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
281
引用
收藏
页码：244A / 244A
页数：1
相关论文
共 50 条
  • [21] Durability of Sustained Virologic Response in Chronic Hepatitis C
    Uyanikoglu, Ahmet
    Kaymakoglu, Sabahattin
    Danalioglu, Ahmet
    Akyuz, Filiz
    Ermis, Fatih
    Pinarbasi, Binnur
    Demir, Kadir
    Besisik, Fatih
    Cakaloglu, Yilmaz
    GUT AND LIVER, 2013, 7 (04) : 458 - 461
  • [22] Is sustained virologic response durable in patients with chronic hepatitis C treated with interferon alfa with or without ribavirin?
    Cheinquer, N
    Cheinquer, H
    Coelho-Borges, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 103 - 103
  • [23] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [24] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [25] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    Davis, GL
    Esteban-Mur, R
    Rustgi, V
    Hoefs, J
    Gordon, SC
    Trepo, C
    Shiffman, ML
    Zeuzem, S
    Craxi, A
    Ling, MH
    Albrecht, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1493 - 1499
  • [26] Combination treatment with consensus-interferon and ribavirin for chronic hepatitis C patients with non-response relapse to previous treatment with alpha-interferon and ribavirin.
    Buggisch, P
    Seegers, B
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    de Heer, G
    Wursthorn, K
    Sterneck, M
    HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [27] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    McHutchison, JG
    Gordon, SC
    Schiff, ER
    Shiffman, ML
    Lee, WM
    Rustgi, VK
    Goodman, ZD
    Ling, MH
    Cort, S
    Albrecht, JK
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1485 - 1492
  • [28] Triple combination treatment of chronic hepatitis C is effective in nonresponders to interferon plus ribavirin.
    Stauber, RE
    Hegenbarth, KS
    Hackl, F
    Hofer, H
    Munda-Steindl, P
    Ferenci, P
    HEPATOLOGY, 2000, 32 (04) : 558A - 558A
  • [29] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
  • [30] Effectiveness of Interferon α-2b and Ribavirin Combination Therapy in the Treatment of Naive Chronic Hepatitis C Patients in Clinical Practice
    Shehab, Thomas M.
    Fontana, Robert J.
    Oberhelman, Kelly
    Marrero, Jorge A.
    Su, Grace L.
    Lok, Anna S. F.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (05) : 425 - 431
12345